Patents by Inventor Kennett Sprogøe

Kennett Sprogøe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTION AND TREATMENT OF OCULAR CONDITIONS
    Publication number: 20170112939
    Abstract: The present invention relates to pharmaceutical compositions comprising hydrogel-linked prodrug for use in the treatment, prevention and/or diagnosis a condition of the eye and ophthalmic devices comprising said pharmaceutical compositions.
    Type: Application
    Filed: January 6, 2017
    Publication date: April 27, 2017
    Applicant: Ascendis Pharma Ophthamology Division A/S
    Inventors: Thomas KNAPPE, Burkhardt Laufer, Harald Rau, Kennett Sprogøe, Tobias Voight, Samuel Weisbrod
  • Carrier-linked treprostinil prodrugs
    Patent number: 9561287
    Abstract: The present invention relates to prodrugs or a pharmaceutically acceptable salt thereof comprising a covalent treprostinil carrier conjugate as well as pharmaceutical composition comprising said compounds. The compounds may be used as medicaments, especially for diseases or disorders which can be treated by treprostinil, such as pulmonary arterial hypertension (PAH).
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: February 7, 2017
    Assignee: Ascendis Pharma A/S
    Inventors: Ulrich Hersel, Harald Rau, Torben Lessmann, Nicola Bisek, Guillaume Maitro, Kennett Sprogøe, Thomas Wegge, Oliver Keil, Joachim Zettler
  • Relaxin Prodrugs
    Publication number: 20160296600
    Abstract: The present invention relates to a carrier-linked relaxin prodrug, pharmaceutical compositions comprising said prodrug, their use as medicaments for the treatment of diseases which can be treated with relaxin, methods of application of such carrier-linked relaxin prodrug or pharmaceutical compositions, methods of treatment, and containers comprising such prodrug or compositions.
    Type: Application
    Filed: November 10, 2014
    Publication date: October 13, 2016
    Applicant: Ascendis Pharma Relaxin Division A/S
    Inventors: Kennett Sprogøe, Felix Cleemann, Harald Rau, Nicole Hassepass, Thomas Wegge, Joachim Zettler, Ana Bernhard
  • VEGF Neutralizing Prodrugs for the Treatment of Ocular Conditions
    Publication number: 20150297740
    Abstract: The present invention relates to a pharmaceutical composition comprising one or more pharmaceutically acceptable excipient(s) and a VEGF neutralizing prodrug, which comprises a VEGF neutralizing biologically active moiety, for use in a method for the treatment of one or more ocular conditions.
    Type: Application
    Filed: October 8, 2013
    Publication date: October 22, 2015
    Inventors: Harald RAU, Thomas KNAPPE, Burkhardt Laufer, Romy REIMANN, Samuel WEISBROD, Kennett SPROGØE, Nicola BISEK, Sebastian STARK, Tobias VOIGT
  • DIAGNOSIS, PREVENTION AND TREATMENT OF DISEASES OF THE JOINT
    Publication number: 20150290337
    Abstract: The present invention relates to apolymeric prodrug for use in the treatment, prevention and/or diagnosis a disease of the joint and pharmaceutical compositions and medical devices comprising said polymeric prodrugs.
    Type: Application
    Filed: October 8, 2013
    Publication date: October 15, 2015
    Inventors: Dirk Vetter, Ulrich Hersel, Kennett Sprogøe, Nora Kaluza, Oliver Keil, Guillaume Maitro, Harald Rau
  • PREVENTION AND TREATMENT OF OCULAR CONDITIONS
    Publication number: 20150010634
    Abstract: The present invention relates to pharmaceutical compositions comprising hydrogel-linked prodrug for use in the treatment, prevention and/or diagnosis a condition of the eye and ophthalmic devices comprising said pharmaceutical compositions.
    Type: Application
    Filed: October 11, 2012
    Publication date: January 8, 2015
    Applicant: Ascendis Pharma Ophthamology Division A/S
    Inventors: Thomas Knappe, Burkhardt Laufer, Harald Rau, Kennett Sprogøe, Tobias Voigt, Samuel Weisbrod
  • Sustained Release Composition of Prostacyclin
    Publication number: 20140303245
    Abstract: The present invention relates to sustained release compositions of prostacyclin, as well as uses thereof, in particular for the prevention and/or treatment of pulmonary arterial hypertension.
    Type: Application
    Filed: August 10, 2012
    Publication date: October 9, 2014
    Applicant: Ascendis Pharma A/S
    Inventors: Kennett Sprogøe, Harald Rau, Ulrich Hersel, Thomas Wegge, Oliver Keil, Joachim Zettler
  • Carrier-Linked Treprostinil Prodrugs
    Publication number: 20140296150
    Abstract: The present invention relates to prodrugs or a pharmaceutically acceptable salt thereof comprising a covalent treprostinil carrier conjugate as well as pharmaceutical composition comprising said compounds. The compounds may be used as medicaments, especially for diseases or disorders which can be treated by treprostinil, such as pulmonary arterial hypertension (PAH).
    Type: Application
    Filed: August 10, 2012
    Publication date: October 2, 2014
    Applicant: Ascendis Pharma A/S
    Inventors: Ulrich Hersel, Harald Rau, Torben Lessmann, Nicola Bisek, Guillaume Maitro, Kennett Sprogøe, Thomas Wegge, Oliver Keil, Joachim Zettler
  • Subcutaneous paliperidone composition
    Patent number: 8758780
    Abstract: The present invention relates to pharmaceutical composition for subcutaneous injection comprising a paliperidone compound wherein the composition releases the paliperidone with an immediate onset of action and continuously for at least 3 weeks, and wherein the composition has a pharmacokinetic profile in vivo with substantially no burst release of the paliperidone. The compositions are useful as medicaments for the treatment of psychotic disorders and diseases.
    Type: Grant
    Filed: October 6, 2010
    Date of Patent: June 24, 2014
    Assignee: Ascendis Pharma AS
    Inventors: Kennett Sprogøe, Ulrich Hersel, Harald Rau, Guillaume Maitro, Thomas Wegge
  • SUBCUTANEOUS PALIPERIDONE COMPOSITION
    Publication number: 20120277253
    Abstract: The present invention relates to pharmaceutical composition for subcutaneous injection comprising a paliperidone compound wherein the composition releases the paliperidone with an immediate onset of action and continuously for at least 3 weeks, and wherein the composition has a pharmacokinetic profile in vivo with substantially no burst release of the paliperidone. The compositions are useful as medicaments for the treatment of psychotic disorders and diseases.
    Type: Application
    Filed: October 6, 2010
    Publication date: November 1, 2012
    Inventors: Kennett Sprogøe, Ulrich Hersel, Harald Rau, Guillaume Maitro, Thomas Wegge